Cefdinir/Clavulanic Acid

头孢地尼/克拉维酸

Report date: 2026/04/21 20:00:18

Base Information

Drug NameCefdinir/Clavulanic Acid

Drug Alias NameClavulanic Acid/Cefdinir film coated tabletsFULLCEF PLUS

ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics

Mechanisms of ActionBeta Lactamase inhibitorsCell wall inhibitorsBacterial penicillin-binding protein inhibitors

TargetsBeta LactamaseBacterial penicillin-binding protein

Therapy Area/IndicationsRespiratory Tract Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesNeutec Pharma Ltd

China Registration ClassN/A

Active CompaniesNeutec Pharma

Inactive CompaniesN/A

Active IndicationsRespiratory Tract Infections

Inactive IndicationsN/A

ATC CodeJ